Home
Goldman Sachs Group reported a 4.1% stake in Oaktree Acquisition Corp. III Life Sciences OACC · 803,487 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.1%
- Last report
- 6.7% · filed 25/05/09
- Shares held
- 803,487 sh
- Class
- Class A ordinary shares, par value $0.0001 per share
- Holder
- Goldman Sachs Group
- Event date
- 25/06/30
- Filed
- 25/08/12
4.1% stake · below 5%
- Stake
- 4.1%
- Last report
- 6.7%
- Since last report
- −2.6pp
Oaktree Acquisition Corp. III Life Sciences trades, last 26 weeks
What else happened in Oaktree Acquisition Corp. III Life Sciences around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Goldman Sachs Group's other 5% stake reports
- Goldman Sachs Group
5% stakeFuture Money Acquisition
5% stakeFuture Money Acquisition
FMAC
7.5% stake
1,184,873 sh
7.5% stake
Filed 08/14
- Goldman Sachs Group
5% stakeBreeze Acquisition Corp. II
5% stakeBreeze Acquisition Corp. II
BREZ
6.7% stake
970,701 sh
6.7% stake
Filed 08/14
- Goldman Sachs Group
5% stakeAmerican Exceptionalism Acquisition Corp. A
5% stakeAmerican Exceptionalism Acquisition Corp. A
AEXA
4.2% stake
1,444,735 sh
4.2% stake
Filed 08/14
- Goldman Sachs Group
5% stakeApex Tech Acquisition
5% stakeApex Tech Acquisition
TRAD
7.6% stake
1,076,558 sh
7.6% stake
Filed 08/14
- Goldman Sachs Group
5% stakeTango Therapeutics
5% stakeTango Therapeutics
TNGX
6% stake
9,742,402.8 sh
6% stake
Filed 08/14
